Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statements on FormS-8 of our reports dated March 16, 2018, with respect to the consolidated financial statements of Eloxx Pharmaceuticals, Inc. included in the annual report on Form10-K of Eloxx Pharmaceuticals, Inc. for the year ended December 31, 2017, filed with the Securities and Exchange Commission.
Tel Aviv, Israel | /s/ Kost Forer Gabbay & Kasierer | |||||
KOST FORER GABBAY & KASIERER | ||||||
May 11, 2018 | A member of Ernst & Young Global |